318 related articles for article (PubMed ID: 23214288)
21. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
Zlatkov V; Kostova P
Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
[TBL] [Abstract][Full Text] [Related]
22. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
23. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
Arbyn M; Dillner J
J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
[TBL] [Abstract][Full Text] [Related]
24. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
Wheeler CM
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
26. Advantages and disadvantages of current prophylactic vaccines against HPV.
Madrid-Marina V; Torres-Poveda K; López-Toledo G; García-Carrancá A
Arch Med Res; 2009 Aug; 40(6):471-7. PubMed ID: 19853187
[TBL] [Abstract][Full Text] [Related]
27. Prevention of carcinoma of cervix with human papillomavirus vaccine.
Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
[TBL] [Abstract][Full Text] [Related]
28. [Human papillomavirus: a vaccine against cervical carcinoma uterine].
Franceschi S
Epidemiol Prev; 2002; 26(3):140-4. PubMed ID: 12197051
[TBL] [Abstract][Full Text] [Related]
29. The natural history of cervical HPV infection: unresolved issues.
Woodman CB; Collins SI; Young LS
Nat Rev Cancer; 2007 Jan; 7(1):11-22. PubMed ID: 17186016
[TBL] [Abstract][Full Text] [Related]
30. The HPV vaccination strategy: could male vaccination have a significant impact?
Brown V; White KA
Comput Math Methods Med; 2010 Sep; 11(3):223-37. PubMed ID: 20582762
[TBL] [Abstract][Full Text] [Related]
31. Getting to know human papillomavirus (HPV) and the HPV vaccines.
Smith GD; Travis L
J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
[TBL] [Abstract][Full Text] [Related]
32. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
33. The epidemiology behind the HPV vaccine discovery.
Koutsky L
Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
[TBL] [Abstract][Full Text] [Related]
34. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus and genital cancer.
Rapose A
Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
[TBL] [Abstract][Full Text] [Related]
36. [Biology of the papillomavirus infections: V. Vaccine developments].
Seilles E; Riethmuller D; Mougin C
Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
Paavonen J
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
[TBL] [Abstract][Full Text] [Related]
38. The epidemiology of human papillomavirus infections.
Baseman JG; Koutsky LA
J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
[TBL] [Abstract][Full Text] [Related]
39. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
Mahdavi A; Monk BJ
Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
[TBL] [Abstract][Full Text] [Related]
40. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]